{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:46:51Z","timestamp":1772560011072,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T00:00:00Z","timestamp":1491523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T00:00:00Z","timestamp":1491523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>FoxM1b is a cell cycle-regulated transcription factor, whose over-expression is a marker for poor outcome in cancers. Its transcriptional activation function requires phosphorylation by Cdk1 or Cdk2 that primes FoxM1b for phosphorylation by Plk1, which triggers association with the co-activator CBP. FoxM1b also possesses transcriptional repression function. It represses the mammary differentiation gene GATA3 involving DNMT3b and Rb. We investigated what determines the two distinct functions of FoxM1b: activation and repression. We show that Rb binds to the C-terminal activation domain of FoxM1b. Analyses with phospho-defective and phospho-mimetic mutants of FoxM1b identified a critical role of the Plk1 phosphorylation sites in regulating the binding of FoxM1b to Rb and DNMT3b. That is opposite of what was seen for the interaction of FoxM1b with CBP. We show that, in addition to GATA3, FoxM1b also represses the mammary luminal differentiation marker FoxA1 by promoter-methylation, and that is regulated by the Plk1 phosphorylation sites in FoxM1b. Our results show that the Plk1 phosphorylation sites in FoxM1b serve as a regulator for its repressor function, and they provide insights into how FoxM1b inhibits differentiation genes and activates proliferation genes during cancer progression.<\/jats:p>","DOI":"10.1038\/srep46017","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T10:05:35Z","timestamp":1491559535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Plk1 Regulates the Repressor Function of FoxM1b by inhibiting its Interaction with the Retinoblastoma Protein"],"prefix":"10.1038","volume":"7","author":[{"given":"Nishit K.","family":"Mukhopadhyay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaibhav","family":"Chand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragana","family":"Kopanja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janai R.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiubei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradip","family":"Raychaudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"key":"BFsrep46017_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.celrep.2012.05.005","volume":"1","author":"JR Carr","year":"2012","unstructured":"Carr, J. R. et al. FoxM1 regulates mammary luminal cell fate. Cell Rep 1, 715\u2013729, doi: 10.1016\/j.celrep.2012.05.005 (2012).","journal-title":"Cell Rep"},{"key":"BFsrep46017_CR2","first-page":"57","volume":"35","author":"RE Francis","year":"2009","unstructured":"Francis, R. E. et al. FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer. Int J Oncol 35, 57\u201368 (2009).","journal-title":"Int J Oncol"},{"key":"BFsrep46017_CR3","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3892\/or.2011.1230","volume":"25","author":"HC Sun","year":"2011","unstructured":"Sun, H. C. et al. Overexpression of Forkhead box M1 protein associates with aggressive tumor features and poor prognosis of hepatocellular carcinoma. Oncol Rep 25, 1533\u20131539, doi: 10.3892\/or.2011.1230 (2011).","journal-title":"Oncol Rep"},{"key":"BFsrep46017_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jhep.2015.03.023","volume":"63","author":"D Kopanja","year":"2015","unstructured":"Kopanja, D. et al. Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features. Journal of hepatology 63, 429\u2013436, doi: 10.1016\/j.jhep.2015.03.023 (2015).","journal-title":"Journal of hepatology"},{"key":"BFsrep46017_CR5","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1038\/onc.2013.475","volume":"33","author":"IC Wang","year":"2014","unstructured":"Wang, I. C. et al. Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic Kras(G12D.). Oncogene 33, 5391\u20135396, doi: 10.1038\/onc.2013.475 (2014).","journal-title":"Oncogene"},{"key":"BFsrep46017_CR6","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.3892\/or.2014.3129","volume":"31","author":"FF Kong","year":"2014","unstructured":"Kong, F. F. et al. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer. Oncol Rep 31, 2660\u20132668, doi: 10.3892\/or.2014.3129 (2014).","journal-title":"Oncol Rep"},{"key":"BFsrep46017_CR7","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1158\/0008-5472.CAN-05-3138","volume":"66","author":"TV Kalin","year":"2006","unstructured":"Kalin, T. V. et al. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res 66, 1712\u20131720, doi: 66\/3\/1712 (2006).","journal-title":"Cancer Res"},{"key":"BFsrep46017_CR8","doi-asserted-by":"publisher","first-page":"22527","DOI":"10.1074\/jbc.M113.455089","volume":"288","author":"Y Cai","year":"2013","unstructured":"Cai, Y. et al. Foxm1 expression in prostate epithelial cells is essential for prostate carcinogenesis. The Journal of biological chemistry 288, 22527\u201322541, doi: 10.1074\/jbc.M113.455089 (2013).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep46017_CR9","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1158\/0008-5472.CAN-14-1952","volume":"75","author":"M Quan","year":"2015","unstructured":"Quan, M. et al. Merlin\/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt\/beta-Catenin Signaling. Cancer research 75, 4778\u20134789, doi: 10.1158\/0008-5472.CAN-14-1952 (2015).","journal-title":"Cancer research"},{"key":"BFsrep46017_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bbcan.2014.01.002","volume":"1845","author":"C Huang","year":"2014","unstructured":"Huang, C., Du, J. & Xie, K. FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis. Biochim Biophys Acta 1845, 104\u2013116, doi: 10.1016\/j.bbcan.2014.01.002 (2014).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep46017_CR11","doi-asserted-by":"publisher","first-page":"e113478","DOI":"10.1371\/journal.pone.0113478","volume":"9","author":"F Zhao","year":"2014","unstructured":"Zhao, F. et al. Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance. PLoS One 9, e113478, doi: 10.1371\/journal.pone.0113478 (2014).","journal-title":"PLoS One"},{"key":"BFsrep46017_CR12","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.2174\/1381612821666141211115949","volume":"21","author":"Z Wang","year":"2015","unstructured":"Wang, Z., Zhang, S., Siu, T. L. & Huang, S. Glioblastoma multiforme formation and EMT: role of FoxM1 transcription factor. Curr Pharm Des 21, 1268\u20131271 (2015).","journal-title":"Curr Pharm Des"},{"key":"BFsrep46017_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00066-015-0840-4","volume":"191","author":"PY Huang","year":"2015","unstructured":"Huang, P. Y. et al. Expression of Aurora-B and FOXM1 predict poor survival in patients with nasopharyngeal carcinoma. Strahlenther Onkol 191, 649\u2013655, doi: 10.1007\/s00066-015-0840-4 (2015).","journal-title":"Strahlenther Onkol"},{"key":"BFsrep46017_CR14","first-page":"2427","volume":"34","author":"A Takata","year":"2014","unstructured":"Takata, A. et al. Clinicopathological and prognostic significance of FOXM1 expression in esophageal squamous cell carcinoma. Anticancer Res 34, 2427\u20132432 (2014).","journal-title":"Anticancer Res"},{"key":"BFsrep46017_CR15","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.1038\/ncomms7471","volume":"6","author":"M Buchner","year":"2015","unstructured":"Buchner, M. et al. Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia. Nat Commun 6, 6471, doi: 10.1038\/ncomms7471 (2015).","journal-title":"Nat Commun"},{"key":"BFsrep46017_CR16","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"Gentles, A. J. et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 21, 938\u2013945, doi: 10.1038\/nm.3909 (2015).","journal-title":"Nat Med"},{"key":"BFsrep46017_CR17","doi-asserted-by":"publisher","first-page":"11281","DOI":"10.18632\/oncotarget.3596","volume":"6","author":"G Yu","year":"2015","unstructured":"Yu, G. et al. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF\/AKT signaling pathway. Oncotarget 6, 11281\u201311294, doi: 10.18632\/oncotarget.3596 (2015).","journal-title":"Oncotarget"},{"key":"BFsrep46017_CR18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1172\/JCI71104","volume":"124","author":"J Xue","year":"2014","unstructured":"Xue, J. et al. Sustained activation of SMAD3\/SMAD4 by FOXM1 promotes TGF-beta-dependent cancer metastasis. The Journal of clinical investigation 124, 564\u2013579, doi: 10.1172\/JCI71104 (2014).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep46017_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ccr.2011.08.016","volume":"20","author":"N Zhang","year":"2011","unstructured":"Zhang, N. et al. FoxM1 promotes beta-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell 20, 427\u2013442, doi: 10.1016\/j.ccr.2011.08.016 (2011).","journal-title":"Cancer Cell"},{"key":"BFsrep46017_CR20","doi-asserted-by":"publisher","first-page":"18662","DOI":"10.1074\/jbc.M115.662882","volume":"290","author":"J Xue","year":"2015","unstructured":"Xue, J. et al. Forkhead Box M1 Is Essential for Nuclear Localization of Glioma-associated Oncogene Homolog 1 in Glioblastoma Multiforme Cells by Promoting Importin-7 Expression. The Journal of biological chemistry 290, 18662\u201318670, doi: 10.1074\/jbc.M115.662882 (2015).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep46017_CR21","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1158\/0008-5472.CAN-14-2800","volume":"75","author":"AH Gong","year":"2015","unstructured":"Gong, A. H. et al. FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells. Cancer research 75, 2337\u20132348, doi: 10.1158\/0008-5472.CAN-14-2800 (2015).","journal-title":"Cancer research"},{"key":"BFsrep46017_CR22","doi-asserted-by":"publisher","first-page":"E3402","DOI":"10.1073\/pnas.1420005112","volume":"112","author":"TS Eisinger-Mathason","year":"2015","unstructured":"Eisinger-Mathason, T. S. et al. Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis. P Natl Acad Sci USA 112, E3402\u20133411, doi: 10.1073\/pnas.1420005112 (2015).","journal-title":"P Natl Acad Sci USA"},{"key":"BFsrep46017_CR23","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1038\/onc.2009.282","volume":"28","author":"AM Barsotti","year":"2009","unstructured":"Barsotti, A. M. & Prives, C. Pro-proliferative FoxM1 is a target of p53-mediated repression. Oncogene 28, 4295\u20134305, doi: onc2009282 (2009).","journal-title":"Oncogene"},{"key":"BFsrep46017_CR24","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.4161\/cc.8.20.9628","volume":"8","author":"B Pandit","year":"2009","unstructured":"Pandit, B., Halasi, M. & Gartel, A. L. p53 negatively regulates expression of FoxM1. Cell Cycle 8, 3425\u20133427, doi: 9628 (2009).","journal-title":"Cell Cycle"},{"key":"BFsrep46017_CR25","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1101\/gad.1200704 18\/7\/830","volume":"18","author":"VV Kalinichenko","year":"2004","unstructured":"Kalinichenko, V. V. et al. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev 18, 830\u2013850, doi: 10.1101\/gad.1200704 18\/7\/830 (2004).","journal-title":"Genes Dev"},{"key":"BFsrep46017_CR26","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1158\/1078-0432.CCR-14-2437","volume":"21","author":"Z Li","year":"2015","unstructured":"Li, Z. et al. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness. Clin Cancer Res 21, 844\u2013853, doi: 10.1158\/1078-0432.CCR-14-2437 (2015).","journal-title":"Clin Cancer Res"},{"key":"BFsrep46017_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/ncb1217","volume":"7","author":"J Laoukili","year":"2005","unstructured":"Laoukili, J. et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 7, 126\u2013136, doi: ncb1217 (2005).","journal-title":"Nat Cell Biol"},{"key":"BFsrep46017_CR28","doi-asserted-by":"publisher","first-page":"10875","DOI":"10.1128\/MCB.25.24.10875-10894.2005","volume":"25","author":"IC Wang","year":"2005","unstructured":"Wang, I. C. et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 25, 10875\u201310894, doi: 25\/24\/10875 (2005).","journal-title":"Mol Cell Biol"},{"key":"BFsrep46017_CR29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1101\/gad.181933.111","volume":"26","author":"S Sadasivam","year":"2012","unstructured":"Sadasivam, S., Duan, S. & DeCaprio, J. A. The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression. Gene Dev 26, 474\u2013489, doi: 10.1101\/gad.181933.111 (2012).","journal-title":"Gene Dev"},{"key":"BFsrep46017_CR30","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1038\/emboj.2009.239","volume":"28","author":"HJ Park","year":"2009","unstructured":"Park, H. J. et al. FoxM1, a critical regulator of oxidative stress during oncogenesis. Embo J 28, 2908\u20132918, doi: emboj2009239 (2009).","journal-title":"Embo J"},{"key":"BFsrep46017_CR31","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1158\/1078-0432.CCR-13-2407","volume":"20","author":"J Cui","year":"2014","unstructured":"Cui, J. et al. FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression. Clin Cancer Res 20, 2595\u20132606, doi: 10.1158\/1078-0432.CCR-13-2407 (2014).","journal-title":"Clin Cancer Res"},{"key":"BFsrep46017_CR32","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1158\/0008-5472.CAN-11-0640","volume":"71","author":"P Raychaudhuri","year":"2011","unstructured":"Raychaudhuri, P. & Park, H. J. FoxM1: A Master Regulator of Tumor Metastasis. Cancer Res 71, 4329\u20134333, doi: 0008-5472.CAN-11-0640 (2011).","journal-title":"Cancer Res"},{"key":"BFsrep46017_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/emmm.201000107","volume":"3","author":"HJ Park","year":"2011","unstructured":"Park, H. J. et al. Deregulation of FoxM1b leads to tumour metastasis. EMBO Mol Med 3, 21\u201334, doi: 10.1002\/emmm.201000107 (2011).","journal-title":"EMBO Mol Med"},{"key":"BFsrep46017_CR34","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.18632\/oncotarget.2957","volume":"6","author":"WT Chiu","year":"2015","unstructured":"Chiu, W. T. et al. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells. Oncotarget 6, 2349\u20132365, doi: 10.18632\/oncotarget.2957 (2015).","journal-title":"Oncotarget"},{"key":"BFsrep46017_CR35","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3748\/wjg.v21.i1.196","volume":"21","author":"FD Meng","year":"2015","unstructured":"Meng, F. D. et al. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. World journal of gastroenterology 21, 196\u2013213, doi: 10.3748\/wjg.v21.i1.196 (2015).","journal-title":"World journal of gastroenterology"},{"key":"BFsrep46017_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.canlet.2013.07.004","volume":"340","author":"C Yang","year":"2013","unstructured":"Yang, C. et al. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer. Cancer Lett 340, 104\u2013112, doi: 10.1016\/j.canlet.2013.07.004 (2013).","journal-title":"Cancer Lett"},{"key":"BFsrep46017_CR37","doi-asserted-by":"publisher","first-page":"8027","DOI":"10.1093\/nar\/gkq715","volume":"38","author":"Z Xie","year":"2010","unstructured":"Xie, Z. et al. Foxm1 transcription factor is required for maintenance of pluripotency of P19 embryonal carcinoma cells. Nucleic Acids Res 38, 8027\u20138038, doi: gkq715 (2010).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep46017_CR38","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1158\/0008-5472.CAN-10-4087","volume":"71","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. FoxM1 in tumorigenicity of the neuroblastoma cells and renewal of the neural progenitors. Cancer Res 71, 4292\u20134302, doi: 0008-5472.CAN-10-4087 (2011).","journal-title":"Cancer Res"},{"key":"BFsrep46017_CR39","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.bbagrm.2014.09.016","volume":"1839","author":"S Zona","year":"2014","unstructured":"Zona, S., Bella, L., Burton, M. J., Nestal de Moraes, G. & Lam, E. W. FOXM1: an emerging master regulator of DNA damage response and genotoxic agent resistance. Biochim Biophys Acta 1839, 1316\u20131322, doi: 10.1016\/j.bbagrm.2014.09.016 (2014).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep46017_CR40","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1158\/0008-5472.CAN-10-0545","volume":"70","author":"JR Carr","year":"2010","unstructured":"Carr, J. R., Park, H. J., Wang, Z., Kiefer, M. M. & Raychaudhuri, P. FoxM1 mediates resistance to herceptin and paclitaxel. Cancer Res 70, 5054\u20135063, doi: 0008-5472.CAN-10-0545 (2010).","journal-title":"Cancer Res"},{"key":"BFsrep46017_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1158\/1541-7786.MCR-09-0432","volume":"8","author":"JM Kwok","year":"2010","unstructured":"Kwok, J. M. et al. FOXM1 confers acquired cisplatin resistance in breast cancer cells. Mol Cancer Res 8, 24\u201334, doi: 1541-7786.MCR-09-0432 (2010).","journal-title":"Mol Cancer Res"},{"key":"BFsrep46017_CR42","doi-asserted-by":"crossref","unstructured":"Fu, Z. et al. Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression. Nat Cell Biol, doi: ncb1767 (2008).","DOI":"10.1038\/ncb1767"},{"key":"BFsrep46017_CR43","doi-asserted-by":"publisher","first-page":"30695","DOI":"10.1074\/jbc.M109.007997","volume":"284","author":"YJ Chen","year":"2009","unstructured":"Chen, Y. J. et al. A conserved phosphorylation site within the forkhead domain of FoxM1B is required for its activation by cyclin-CDK1. J Biol Chem 284, 30695\u201330707, doi: M109.007997 (2009).","journal-title":"J Biol Chem"},{"key":"BFsrep46017_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/ncb0205-108","volume":"7","author":"RH Costa","year":"2005","unstructured":"Costa, R. H. FoxM1 dances with mitosis. Nature cell biology 7, 108\u2013110, doi: 10.1038\/ncb0205-108 (2005).","journal-title":"Nature cell biology"},{"key":"BFsrep46017_CR45","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.4161\/cc.7.17.6580","volume":"7","author":"J Laoukili","year":"2008","unstructured":"Laoukili, J., Alvarez-Fernandez, M., Stahl, M. & Medema, R. H. FoxM1 is degraded at mitotic exit in a Cdh1-dependent manner. Cell Cycle 7, 2720\u20132726, doi: 6580 (2008).","journal-title":"Cell Cycle"},{"key":"BFsrep46017_CR46","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.1128\/MCB.00387-08","volume":"28","author":"HJ Park","year":"2008","unstructured":"Park, H. J., Costa, R. H., Lau, L. F., Tyner, A. L. & Raychaudhuri, P. Anaphase-promoting complex\/cyclosome-CDH1-mediated proteolysis of the forkhead box M1 transcription factor is critical for regulated entry into S phase. Mol Cell Biol 28, 5162\u20135171, doi: MCB.00387-08 (2008).","journal-title":"Mol Cell Biol"},{"key":"BFsrep46017_CR47","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ccr.2011.10.001","volume":"20","author":"L Anders","year":"2011","unstructured":"Anders, L. et al. A systematic screen for CDK4\/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell 20, 620\u2013634, doi: 10.1016\/j.ccr.2011.10.001 (2011).","journal-title":"Cancer Cell"},{"key":"BFsrep46017_CR48","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1128\/MCB.24.7.2649-2661.2004","volume":"24","author":"ML Major","year":"2004","unstructured":"Major, M. L., Lepe, R. & Costa, R. H. Forkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300\/CBP coactivators. Mol Cell Biol 24, 2649\u20132661 (2004).","journal-title":"Mol Cell Biol"},{"key":"BFsrep46017_CR49","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1515\/BC.2006.119","volume":"387","author":"I Wierstra","year":"2006","unstructured":"Wierstra, I. & Alves, J. Transcription factor FOXM1c is repressed by RB and activated by cyclin D1\/Cdk4. Biol Chem 387, 949\u2013962, doi: 10.1515\/BC.2006.119 (2006).","journal-title":"Biol Chem"},{"key":"BFsrep46017_CR50","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1128\/MCB.01710-07","volume":"28","author":"J Laoukili","year":"2008","unstructured":"Laoukili, J. et al. Activation of FoxM1 during G2 requires cyclin A\/Cdk-dependent relief of autorepression by the FoxM1 N-terminal domain. Mol Cell Biol 28, 3076\u20133087, doi: MCB.01710-07 (2008).","journal-title":"Mol Cell Biol"},{"key":"BFsrep46017_CR51","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/sj.onc.1210814","volume":"27","author":"HJ Park","year":"2008","unstructured":"Park, H. J. et al. An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle. Oncogene 27, 1696\u20131704, (2008) doi: 1210814.","journal-title":"Oncogene"},{"key":"BFsrep46017_CR52","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1128\/MCB.16.2.694","volume":"16","author":"D Parker","year":"1996","unstructured":"Parker, D. et al. Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol Cell Biol 16, 694\u2013703 (1996).","journal-title":"Mol Cell Biol"},{"key":"BFsrep46017_CR53","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.tcb.2015.07.007","volume":"25","author":"S Dalton","year":"2015","unstructured":"Dalton, S. Linking the Cell Cycle to Cell Fate Decisions. Trends Cell Biol 25, 592\u2013600, doi: 10.1016\/j.tcb.2015.07.007 (2015).","journal-title":"Trends Cell Biol"},{"key":"BFsrep46017_CR54","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2015.07.001","volume":"162","author":"KA Gonzales","year":"2015","unstructured":"Gonzales, K. A. et al. Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways. Cell 162, 564\u2013579, doi: 10.1016\/j.cell.2015.07.001 (2015).","journal-title":"Cell"},{"key":"BFsrep46017_CR55","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.stemcr.2013.10.009","volume":"1","author":"AM Singh","year":"2013","unstructured":"Singh, A. M. et al. Cell-cycle control of developmentally regulated transcription factors accounts for heterogeneity in human pluripotent cells. Stem Cell Reports 1, 532\u2013544, doi: 10.1016\/j.stemcr.2013.10.009 (2013).","journal-title":"Stem Cell Reports"},{"key":"BFsrep46017_CR56","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cell.2013.08.031","volume":"155","author":"S Pauklin","year":"2013","unstructured":"Pauklin, S. & Vallier, L. The cell-cycle state of stem cells determines cell fate propensity. Cell 155, 135\u2013147, doi: 10.1016\/j.cell.2013.08.031 (2013).","journal-title":"Cell"},{"key":"BFsrep46017_CR57","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1101\/gad.271452.115","volume":"30","author":"S Pauklin","year":"2016","unstructured":"Pauklin, S., Madrigal, P., Bertero, A. & Vallier, L. Initiation of stem cell differentiation involves cell cycle-dependent regulation of developmental genes by Cyclin D. Gene Dev 30, 421\u2013433, doi: 10.1101\/gad.271452.115 (2016).","journal-title":"Gene Dev"},{"key":"BFsrep46017_CR58","doi-asserted-by":"crossref","unstructured":"Tan, Y., Raychaudhuri, P. & Costa, R. H. Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes. Mol Cell Biol 27, 1007\u20131016, doi: MCB.01068-06.","DOI":"10.1128\/MCB.01068-06"},{"key":"BFsrep46017_CR59","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ccr.2008.01.011","volume":"13","author":"H Kouros-Mehr","year":"2008","unstructured":"Kouros-Mehr, H. et al. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13, 141\u2013152, doi: 10.1016\/j.ccr.2008.01.011 (2008).","journal-title":"Cancer Cell"},{"key":"BFsrep46017_CR60","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1038\/onc.2009.126","volume":"28","author":"AB Dydensborg","year":"2009","unstructured":"Dydensborg, A. B. et al. GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis. Oncogene 28, 2634\u20132642, doi: 10.1038\/onc.2009.126 (2009).","journal-title":"Oncogene"},{"key":"BFsrep46017_CR61","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1186\/bcr2327","volume":"11","author":"A Albergaria","year":"2009","unstructured":"Albergaria, A. et al. Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast Cancer Res 11, R40, doi: 10.1186\/bcr2327 (2009).","journal-title":"Breast Cancer Res"},{"key":"BFsrep46017_CR62","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/hmg\/10.7.699","volume":"10","author":"JR Nevins","year":"2001","unstructured":"Nevins, J. R. The Rb\/E2F pathway and cancer. Hum Mol Genet 10, 699\u2013703 (2001).","journal-title":"Hum Mol Genet"},{"key":"BFsrep46017_CR63","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1101\/gad.1676108","volume":"22","author":"T Abbas","year":"2008","unstructured":"Abbas, T. et al. PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev 22, 2496\u20132506 (2008).","journal-title":"Genes Dev"}],"updated-by":[{"DOI":"10.1038\/s41598-018-34071-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep46017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep46017","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/srep46017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/srep46017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:23:08Z","timestamp":1671819788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep46017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,5,31]]}},"alternative-id":["BFsrep46017"],"URL":"https:\/\/doi.org\/10.1038\/srep46017","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]},"assertion":[{"value":"27 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46017"}}